THE HARPLE GROUP, LLC

Lobbying for ELI LILLY & COMPANY · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Indiana · $10,000.00 income · posted Oct 9, 2025

Lobbying activity 1

Health Issues

Monitored Issues and advised clients on matters related to Pharmaceutical supply chain security and resiliency.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.